Pfizer reported $9.91B in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbott ABT:US $ 2018M 429M
Abbvie ABBV:US $ 924M 3566M
ALKERMES ALKS:US $ -30.14M 5.77M
Amgen AMGN:US $ 1317M 159M
AstraZeneca AZN:LN 29568.96M 177.38M
Astrazeneca AZN:US $ 360M 26M
Bayer BAYN:GR € -298M 3589M
Biogen BIIB:US $ 1058M 754.2M
Bristol Myers Squibb BMY:US $ 1421M 143M
Catalent CTLT:US $ 188M 47M
Eli Lilly And LLY:US $ 952.5M 950.4M
Endo International Ordinary Shares ENDP:US $ -1885.43M 1813.45M
Gilead Sciences GILD:US $ 1144M 1125M
GlaxoSmithKline GSK:LN 83800M 96400M
Glaxosmithkline GSK:US $ 838M 964M
Horizon Pharma HZNP:US $ 60.97M 143.29M
Intercept Pharmaceuticals ICPT:US $ -7.53M 9.76M
JAZZ PHA JAZZ:US $ 34.66M 33.02M
Johnson & Johnson JNJ:US $ 4814M 335M
Medtronic MDT:US $ 930M 556M
Merk MRK:US $ 3944M 366M
Neurocrine Biosciences NBIX:US $ -16.9M 30.8M
Novartis NOVN:VX SF 1694M 528M
Novartis NVS:US $ 1694M 528M
Pacira Pharmaceuticals PCRX:US $ 19.88M 13.05M
Perrigo Ordinary Shares PRGO:US $ -65.1M 62.7M
Pfizer PFE:US $ 9905M 2042M
Prestige Brands PBH:US $ 55.27M 3.19M
Regeneron Pharmaceuticals REGN:US $ 852.1M 121.4M
Teva Pharmaceutical Industries TEVA:US $ -233M 722M
Vertex Pharmaceuticals VRTX:US $ 810.5M 48.4M
Zoetis ZTS:US $ 529M 66M